Using contingency management to help people in Hawaii with methamphetamine use
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
This study is testing a new program to see if offering rewards can help people in Hawaii who are recovering from injuries and have used methamphetamine stay on track with their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Queen's Medical Center Academic / other |
| Locations | 1 site (Honolulu, Hawaii) |
| Trial ID | NCT06532370 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to implement a contingency management (CM) program for individuals in Hawaii who are recovering from traumatic injuries and have a history of methamphetamine use. Participants will engage in follow-up visits up to three times a week for urinalysis and complete assessments to evaluate the effectiveness of the CM program. The study will also include qualitative interviews to gather participant perspectives on their experience with the program. The goal is to collect data on the program's effectiveness and participant engagement.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who have been hospitalized for trauma and have a positive urine drug screen for methamphetamines.
Not a fit: Patients with active psychosis, severe traumatic brain injuries, or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve recovery outcomes for individuals struggling with methamphetamine use following traumatic injuries.
How similar studies have performed: Other studies utilizing contingency management have shown promise in treating substance use disorders, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted trauma patients * Age greater than 18 years old * Urine drug screen positive for methamphetamines during the current hospitalization * Report at least weekly methamphetamine use * First methamphetamine use greater than 6 months prior to injury * Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease) * Glasgow Coma Scale ≥13 upon arrival to the emergency department * Ability to understand and participate in study procedures * Ability to communicate in English Exclusion Criteria: * Active psychosis (reporting auditory or visual hallucinations) * Under ongoing cardiorespiratory monitoring * Evidence of moderate or severe traumatic brain injury * Patients who are known to be pregnant * Prisoner * Individuals incarcerated at the time of their hospitalization * Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent
Where this trial is running
Honolulu, Hawaii
- The Queen's Medical Center — Honolulu, Hawaii, United States (Recruiting)
Study contacts
- Study coordinator: Nicholas R Schumann, Clinical Psychologist
- Email: nschumann@queens.org
- Phone: (808) 691-7024
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.